Product ID:ERASE II-METHYLENE CHLORIDE ERASE REMOVER
MSDS Date:09/08/1986
FSC:8010
NIIN:00N031310
MSDS Number: BPHDV

NEW YORK BRONZE POWDER CO INC

777 DOWD AVE
ELIZABETH, NJ 07201
US

Emergency Phone: 800-692-2677

Info Phone: 201-289-4900

Cage: 0AU16

NEW YORK BRONZE INC DIV OF NOVO CORP

ELIZABETH, NJ 07201 US

Cage: 0AU16

METHANE, DICHLORO-; (METHYLENE CHLORIDE) (SARA III)

CAS: 75-09-2

RTECS: PA8050000

Fraction By Weight: 86.18%

OSHA PEL 500 PPM;1000 PPM, C

ACGIH TLV: 50 PPM

EPA Report Quantity: 1000 LBS

DOT Report Quantity: 1000 LBS

METHANOL; (METHYL ALCOHOL)

CAS: 67-56-1

RTECS: PC1400000

Fraction By Weight: 6.46%

OSHA PEL S,200PPM/250STEL

ACGIH TLV: S,200PPM/250STEL; 93

EPA Report Quantity: 5000 LBS

DOT Report Quantity: 5000 LBS

MINERAL SPIRITS

CAS: 64742-88-7

Fraction By Weight: 1.2%

ACGIH TLV: 200 PPM (MFR)

TOLUENE; (TOLUOL) (SARA III)

CAS: 108-88-3

RTECS: XS5250000

Fraction By Weight: 3.5%

OSHA PEL 200 PPM/150 STEL

ACGIH TLV: 50 PPM; 9293

EPA Report Quantity: 1000 LBS

DOT Report Quantity: 1000 LBS

LD50 LC50 Mixture:NONE SPECIFIED BY MANUFACTURER.
Routes of Entry: Inhalation:YES Skin:YES Ingestion:YES
Reports of Carcinogenicity:NTP:YES IARC:YES OSHA:NO
Health Hazards Acute and Chronic:CHLOROCARBON MATERIALS HAVE PRODUCED
SENSITIZATION OF MYOCARDIUM TO EPINEPHRINE IN LAB ANIMALS AND COULD
HAVE A SIMILAR EFFECT IN HUMANS. ADRENOMETICS (E.G., EPINEPHRINE)
MAY BE CONTRAINDICATED EXCEPT FOR LIFE-SUSTAINING USES IN HUMANS
ACUTELY OR CHRONICALLY EXPOSED TO CHLOROCARBONS . (EFTS OF
OVEREXPOS)
Explanation of Carcinogenicity:METHYLENE CHLORIDE:GROUP 2 (NTP), GROUP
2B (IARC).
Effects of Overexposure:HLTH HAZ:CNS DEPRESSION. HEADACHE, NAUSEA,
DIZZINESS AND LOSS OF CONSCIOUSNESS. NOTE:TOLUENE (108-88-3)
APPEARS ON NAVY LISTING OF OCCUPATIONAL REPRODUCTIVE HAZARDS. SEEK
CONSULTATION FROM APPROPRIATE HEALTH PROFESSIONALS CONCERNING
LATESTHAZARD LIST INFORMATION & SAFE HANDLING & EXPOSURE
RECOMMENDATIONS .
Medical Cond Aggravated by Exposure:INCREASES AND SUSTAINS CARBOXY
HEMOGLOBIN LEVELS IN BLOOD, REDUCING OXYGEN CARRYING CAPACITY IN
BLOOD.

First Aid:INHAL:REMOVE TO FRESH AIR. GET MEDICAL ATTENTION IF
NECESSARY. EYES:FLUSH WITH WATER FOR AT LEAST 15 MINUTES. GET
MEDICAL ATTENTION IF NECESSARY. SKIN:WASH WITH SOAP AND WATER AND
REMOVE AFFECTED CLOT HING. INGEST:DO NOT INDUCE VOMITING. GET
MEDICAL ATTENTION.

Flash Point:45.0F,7.2C
Extinguishing Media:WATER, FOG, CARBON DIOXIDE.
Fire Fighting Procedures:WEAR NIOSH/MSHA APPROVED PRESSURE DEMAND SCBA
AND FULL PROTECTIVE EQUIPMENT . EVACUATE HAZARD AREA OF UNPROTECTED
PERSONNEL. COOL SURROUNDING AREAS.
Unusual Fire/Explosion Hazard:THERM DECOMP PROD MAY INCLUDE HCL &
PHOSGENE . TURN OFF ELECT SERVICE TO ELIMINATE SOURCES OF IGNITION
BY SPARK. WHEN HEATED TO DECOMP, IT CAN (SUPDAT)

Spill Release Procedures:DIKE AND CONTAIN. SOAK UP RESIDUE WITH CLAY,
SAND OR OTHER SUITABLE MATERIALS.
Neutralizing Agent:NONE SPECIFIED BY MANUFACTURER.

Handling and Storage Precautions:FLAMMABLE, ELIMINATE ALL IGNITION
SOURCES.
Other Precautions:GROUND MATERIAL IF USED IN LARGE QUANTITIES. NO
SMOKING IN AREA OF USE. DO NOT USE IN GENERAL VICINITY OF ARC
WELDING, OPEN FLAMES OR HOT SURFACES. HEAT AND/OR UV RADIATION MAY
CAUSE FORMATION OF HCL AND/OR PHOSGENE .

Respiratory Protection:NIOSH/MSHA APPROVED RESPIRATOR.
Ventilation:EXPLOSION PROOF VENTILATION TO KEEP BELOW TLV.
Protective Gloves:NEOPRENE GLOVES.
Eye Protection:CHEMICAL WORKERS GOGGLES .
Other Protective Equipment:IMPERVIOUS APRON.
Work Hygienic Practices:WASH THOROUGHLY AFTER EACH USE.
Supplemental Safety and Health
EXPLOS HAZ:EMIT TOXIC FUMES OF CHLORIDES.

HCC:F3
Boiling Pt:B.P. Text:103F,39C
Vapor Density:2.39
Spec Gravity:1.22 (H2O = 1)
Solubility in Water:MINIMAL
Appearance and Odor:COLORLESS SEMI LIQUID WITH TYPICAL PAINT AROMA

Stability Indicator/Materials to Avoid:YES
CONTACT WITH STRONG OXIDANTS.
Stability Condition to Avoid:AVOID HEAT, SPARKS AND OPEN FLAMES.
Hazardous Decomposition Products:HCL, PHOSGENE . UPON INCOMPLETE
COMBUSTION, CO CAN BE FORMED.

Waste Disposal Methods:PLACE IN A DISPOSAL FACILITY APPROVED UNDER RCRA
REGULATIONS. DISPOSAL MUST BE IN ACCORDANCE WITH LOCAL, STATE AND
FEDERAL REGULATIONS .

Disclaimer (provided with this information by the compiling agencies):
This information is formulated for use by elements of the Department
of Defense. The United States of America in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. Any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.